179 related articles for article (PubMed ID: 33893082)
1. Altered Expression of MBNL Family of Alternative Splicing Factors in Colorectal Cancer.
Navvabi N; Kolikova P; Hosek P; Zitricky F; Navvabi A; Vycital O; Bruha J; Palek R; Rosendorf J; Liska V; Pitule P
Cancer Genomics Proteomics; 2021; 18(3):295-306. PubMed ID: 33893082
[TBL] [Abstract][Full Text] [Related]
2. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming.
Han H; Irimia M; Ross PJ; Sung HK; Alipanahi B; David L; Golipour A; Gabut M; Michael IP; Nachman EN; Wang E; Trcka D; Thompson T; O'Hanlon D; Slobodeniuc V; Barbosa-Morais NL; Burge CB; Moffat J; Frey BJ; Nagy A; Ellis J; Wrana JL; Blencowe BJ
Nature; 2013 Jun; 498(7453):241-5. PubMed ID: 23739326
[TBL] [Abstract][Full Text] [Related]
3. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
Terenzi F; Ladd AN
RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.
Snezhkina AV; Krasnov GS; Zaretsky AR; Zhavoronkov A; Nyushko KM; Moskalev AA; Karpova IY; Afremova AI; Lipatova AV; Kochetkov DV; Fedorova MS; Volchenko NN; Sadritdinova AF; Melnikova NV; Sidorov DV; Popov AY; Kalinin DV; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
BMC Genomics; 2016 Dec; 17(Suppl 14):1011. PubMed ID: 28105922
[TBL] [Abstract][Full Text] [Related]
5. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract][Full Text] [Related]
6. An engineered RNA binding protein with improved splicing regulation.
Hale MA; Richardson JI; Day RC; McConnell OL; Arboleda J; Wang ET; Berglund JA
Nucleic Acids Res; 2018 Apr; 46(6):3152-3168. PubMed ID: 29309648
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors.
Fleming VA; Geng C; Ladd AN; Lou H
BMC Mol Biol; 2012 Dec; 13():35. PubMed ID: 23227900
[TBL] [Abstract][Full Text] [Related]
8. miR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL.
Zhang BW; Cai HF; Wei XF; Sun JJ; Lan XY; Lei CZ; Lin FP; Qi XL; Plath M; Chen H
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840300
[TBL] [Abstract][Full Text] [Related]
9. MBNL proteins and their target RNAs, interaction and splicing regulation.
Konieczny P; Stepniak-Konieczna E; Sobczak K
Nucleic Acids Res; 2014; 42(17):10873-87. PubMed ID: 25183524
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
12. HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of
Sakuma K; Sasaki E; Kimura K; Komori K; Shimizu Y; Yatabe Y; Aoki M
Gut; 2018 Jun; 67(6):1103-1111. PubMed ID: 28360095
[TBL] [Abstract][Full Text] [Related]
13. Modulatory role of RNA helicases in MBNL-dependent alternative splicing regulation.
Taylor K; Piasecka A; Kajdasz A; Brzęk A; Polay Espinoza M; Bourgeois CF; Jankowski A; Borowiak M; Raczyńska KD; Sznajder ŁJ; Sobczak K
Cell Mol Life Sci; 2023 Oct; 80(11):335. PubMed ID: 37882878
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis.
Thorsen K; Schepeler T; Øster B; Rasmussen MH; Vang S; Wang K; Hansen KQ; Lamy P; Pedersen JS; Eller A; Mansilla F; Laurila K; Wiuf C; Laurberg S; Dyrskjøt L; Ørntoft TF; Andersen CL
BMC Genomics; 2011 Oct; 12():505. PubMed ID: 21999571
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression.
Hirschfeld M; Zhang B; Jaeger M; Stamm S; Erbes T; Mayer S; Tong X; Stickeler E
Mol Carcinog; 2014 Nov; 53(11):883-92. PubMed ID: 23765422
[TBL] [Abstract][Full Text] [Related]
17. MBNL splicing activity depends on RNA binding site structural context.
Taylor K; Sznajder LJ; Cywoniuk P; Thomas JD; Swanson MS; Sobczak K
Nucleic Acids Res; 2018 Sep; 46(17):9119-9133. PubMed ID: 29955876
[TBL] [Abstract][Full Text] [Related]
18. Splicing regulators in endothelial cell differentiation.
Schiano C; Rienzo M; Casamassimi A; Soricelli A; Napoli C
J Cardiovasc Med (Hagerstown); 2017 Oct; 18(10):742-749. PubMed ID: 28661931
[TBL] [Abstract][Full Text] [Related]
19. Identification of spliced variants of the proto-oncogene HDM2 in colorectal cancer.
Yu Z; Zhang B; Cui B; Wang Y; Han P; Wang X
Cancer; 2012 Feb; 118(4):1110-8. PubMed ID: 21761395
[TBL] [Abstract][Full Text] [Related]
20. Muscleblind proteins regulate alternative splicing.
Ho TH; Charlet-B N; Poulos MG; Singh G; Swanson MS; Cooper TA
EMBO J; 2004 Aug; 23(15):3103-12. PubMed ID: 15257297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
